CN102864125B - 一种单克隆杂交瘤的制备方法 - Google Patents
一种单克隆杂交瘤的制备方法 Download PDFInfo
- Publication number
- CN102864125B CN102864125B CN201210280494.4A CN201210280494A CN102864125B CN 102864125 B CN102864125 B CN 102864125B CN 201210280494 A CN201210280494 A CN 201210280494A CN 102864125 B CN102864125 B CN 102864125B
- Authority
- CN
- China
- Prior art keywords
- cell
- hybridoma
- preparation
- incubator
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title abstract description 41
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 claims abstract description 95
- 210000004408 hybridoma Anatomy 0.000 claims abstract description 75
- 239000007864 aqueous solution Substances 0.000 claims abstract description 21
- 238000002965 ELISA Methods 0.000 claims abstract description 17
- 239000000243 solution Substances 0.000 claims abstract description 16
- 238000012258 culturing Methods 0.000 claims abstract description 14
- 239000000427 antigen Substances 0.000 claims abstract description 11
- 102000036639 antigens Human genes 0.000 claims abstract description 11
- 108091007433 antigens Proteins 0.000 claims abstract description 11
- 238000012216 screening Methods 0.000 claims abstract description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 8
- 206010035226 Plasma cell myeloma Diseases 0.000 claims abstract description 7
- 210000004698 lymphocyte Anatomy 0.000 claims abstract description 7
- 201000000050 myeloid neoplasm Diseases 0.000 claims abstract description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 30
- 235000015097 nutrients Nutrition 0.000 claims description 26
- 210000002966 serum Anatomy 0.000 claims description 17
- 244000309466 calf Species 0.000 claims description 16
- 238000011534 incubation Methods 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- -1 polyoxyethylene Polymers 0.000 claims description 2
- 238000002156 mixing Methods 0.000 abstract description 5
- 238000002649 immunization Methods 0.000 abstract description 4
- 230000003053 immunization Effects 0.000 abstract description 4
- 230000004927 fusion Effects 0.000 abstract description 3
- 239000001963 growth medium Substances 0.000 abstract description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 6
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 3
- 239000001569 carbon dioxide Substances 0.000 abstract 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract 1
- 210000001728 clone cell Anatomy 0.000 abstract 1
- 239000012894 fetal calf serum Substances 0.000 abstract 1
- 238000009630 liquid culture Methods 0.000 abstract 1
- 229940113082 thymine Drugs 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 40
- 229920000609 methyl cellulose Polymers 0.000 description 20
- 239000001923 methylcellulose Substances 0.000 description 20
- 235000010981 methylcellulose Nutrition 0.000 description 20
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 210000004988 splenocyte Anatomy 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 210000004754 hybrid cell Anatomy 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010010254 Concussion Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 229940005654 nitrite ion Drugs 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210280494.4A CN102864125B (zh) | 2012-08-08 | 2012-08-08 | 一种单克隆杂交瘤的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210280494.4A CN102864125B (zh) | 2012-08-08 | 2012-08-08 | 一种单克隆杂交瘤的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102864125A CN102864125A (zh) | 2013-01-09 |
CN102864125B true CN102864125B (zh) | 2014-11-26 |
Family
ID=47443256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210280494.4A Expired - Fee Related CN102864125B (zh) | 2012-08-08 | 2012-08-08 | 一种单克隆杂交瘤的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102864125B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104977408B (zh) * | 2015-06-15 | 2016-09-14 | 暨南大学 | 一种筛选分泌特异性单克隆抗体杂交瘤细胞的方法与应用 |
CN108107205B (zh) * | 2016-11-25 | 2023-10-27 | 南京凌芯生物科技有限公司 | 高通量快速筛选阳性杂交瘤细胞的方法及系统 |
CN113493774B (zh) * | 2020-03-20 | 2024-01-16 | 南京松天盛科生物科技有限公司 | 一种提高杂交瘤细胞融合率的培养基 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101270380A (zh) * | 2008-05-08 | 2008-09-24 | 中国农业科学院油料作物研究所 | 一种杂交瘤细胞单克隆制备的筛选方法 |
-
2012
- 2012-08-08 CN CN201210280494.4A patent/CN102864125B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101270380A (zh) * | 2008-05-08 | 2008-09-24 | 中国农业科学院油料作物研究所 | 一种杂交瘤细胞单克隆制备的筛选方法 |
Non-Patent Citations (4)
Title |
---|
刘帆.固体培养基法制备单抗的可行性研究.《热带医学杂志》.2010, * |
固体培养基法制备单抗的可行性研究;刘帆;《热带医学杂志》;20100430;第384页左栏第5段-第385页左栏第3段 * |
在甲基纤维素半固体培养基上制备抗人黄体生成素McAb;王保君;《中国医学科学院学报》;19921031;第14卷(第5期);382-384 * |
王保君.在甲基纤维素半固体培养基上制备抗人黄体生成素McAb.《中国医学科学院学报》.1992,第14卷(第5期),382-384. * |
Also Published As
Publication number | Publication date |
---|---|
CN102864125A (zh) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102643751B (zh) | 一种快速分离纯化小球藻的方法 | |
CN102864125B (zh) | 一种单克隆杂交瘤的制备方法 | |
CN105132375A (zh) | 一种肝癌干细胞的无血清培养基及其培养方法 | |
CN102485885A (zh) | 脂肪干细胞的分离方法和用途 | |
CN101531996B (zh) | 源于成形组织的间充质干细胞的分离和纯化方法 | |
CN110313401A (zh) | 一种促进企剑白墨墨兰组织培养过程中芽分化的方法 | |
CN103898060B (zh) | Hat半固体筛选培养基以及杂交瘤细胞的筛选方法 | |
CN103555587A (zh) | 一种从自然水体中筛选高油脂藻类的方法 | |
CN101270380A (zh) | 一种杂交瘤细胞单克隆制备的筛选方法 | |
CN105039248A (zh) | 树鼩骨髓间充质干细胞培养系统 | |
CN102002481B (zh) | 猪呼吸与繁殖障碍综合征病毒的生产方法 | |
CN101824459B (zh) | 利用内生真菌诱导子促进白桦悬浮细胞中三萜积累的方法 | |
CN103898063B (zh) | 半固体筛选培养基以及杂交瘤细胞的筛选方法 | |
CN105385608A (zh) | 一种香菇液体菌种深层发酵工艺 | |
CN102002482A (zh) | 猪呼吸与繁殖障碍综合征病毒的生产方法 | |
CN101013135B (zh) | 利用凝集素筛选与非豆科植物具有特异亲和性的功能菌的方法 | |
CN112662583A (zh) | 一种适用于葛仙米营养生长的改良培养基及配制方法 | |
CN101948798B (zh) | 一种羊水来源的间充质干细胞的分离纯化方法 | |
CN104293734A (zh) | 一种人γδT细胞的制备方法 | |
CN1680444A (zh) | 抗香石竹斑驳病毒的单克隆抗体及其用途 | |
CN102978131A (zh) | 一种Vc二步发酵菌株的筛选方法 | |
CN107721536A (zh) | 一种促进平菇菌丝生长及出菇的复合原料 | |
CN109796530A (zh) | 一种杂交瘤细胞过滤灌流培养制备抗体的方法 | |
CN101148655B (zh) | 一种盖玻片上生长细胞克隆球的方法 | |
CN102492653B (zh) | 一种从成体兔的成熟脂肪细胞诱导分化为心肌样细胞的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: YIN ZHIMIN Effective date: 20121225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yin Zhimin Inventor after: Zhou Jun Inventor after: Feng Zhanbo Inventor after: Wang Yuyan Inventor after: Pan Yangbin Inventor before: Zhou Jun Inventor before: Wang Yuyan Inventor before: Feng Zhanbo |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHOU JUN WANG YUYAN FENG ZHANBO TO: YIN ZHIMIN ZHOU JUN FENG ZHANBO WANG YUYAN PAN YANGBIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121225 Address after: Qixia District Maigaoqiao street Nanjing city Jiangsu province 210036 and Yan Road No. 251 Building 1 building 1202 room 18 Applicant after: NANJING BIOGOT BIOTECHNOLOGY CO.,LTD. Applicant after: Yin Zhimin Address before: Qixia District Maigaoqiao street Nanjing city Jiangsu province 210036 and Yan Road No. 251 Building 1 building 1202 room 18 Applicant before: NANJING BIOGOT BIOTECHNOLOGY CO.,LTD. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141126 Termination date: 20210808 |